Skip to main navigation Skip to search Skip to main content

EFFICACY AND SAFETY OF ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS

  • Siamak Daneshmand
  • , Renata Zaucha
  • , Nikhil Vasdev
  • , Benjamin A Gartrell
  • , Yair Lotan
  • , Syed A. Hussain
  • , Eugene K Lee
  • , Giuseppe Procopio
  • , Fernando Galanternik
  • , Geraldine Pignot
  • , Debasish Sundi
  • , Hernan J Cutuli
  • , Lauren Crow
  • , Vahid Naini
  • , Spyros Triantos
  • , Mahadi Baig
  • , Jodi K Maranchie

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Publication statusSubmitted - 13 Jul 2023
EventSociety of Urologic Oncology, 24th Annual General Meeting - Omni Shoreham Hotel, Washington, Dist of Col, United States of America, United States
Duration: 29 Nov 20231 Dec 2023
https://suonet.org/meetings/upcoming-meetings.aspx

Conference

ConferenceSociety of Urologic Oncology, 24th Annual General Meeting
Abbreviated titleSUO 2023
Country/TerritoryUnited States
Period29/11/231/12/23
Internet address

Cite this